Page 1 of 3
123

2025 (1 POST)

Stemer TR, Covington TR, Cowan DW, Coyle JP, Gearhart JM, LaLonde TJ, Ring CL, Sweeney LM, Wambaugh JF, Wooten AT, Bang AG, Clewell RA. Rapid risk assessment of potential neurotoxicants using non-animal test methods. Abstract 4842, Society of Toxicology 64th Annual Meeting, Orlando, FL, March 2025.

View Abstract

2022 (2 POSTS)

Allen DG, Rooney J, To K, Choksi N, Ceger P, Daniel A, et al. Variability in reference test method data and the impact on NAM evaluations. Poster presented at Society of Toxicology 61st Annual Meeting, San Diego, CA, March 2022.

View Abstract

Catalano S, Choksi N, Corvaro M, Kolle S, Stinchombe S, Latorre A, et al. Reducing animal use for eye irritation testing of agrochemicals in Brazil. Poster presented at Society of Toxicology 61st Annual Meeting, San Diego, CA, March 2022.

View Abstract

2021 (6 POSTS)

Robison TW, Heflich RH, Manjanatha MG, Elespuru R, Atrakchi A, Mei N, Ding W. 2021. Appropriate in vivo follow-up assays to an in vitro bacterial reverse mutation (Ames) test positive investigational drug candidate (active pharmaceutical ingredient), drug- related metabolite, or drug-related impurity. Mutat Res Gen Toxicol Environ Mutagen 868-869(Aug-Sept):503386; doi: 10.1016/j.mrgentox.2021.503386.

View Abstract

Rooney JP, Choksi NY, Ceger P, Daniel AB, Truax J, Allen D, Kleinstreuer N 2021. Analysis of variability in in vivo rabbit skin irritation assay results. Regul Toxicol Pharmacol 122(June):104920; doi: 10.1016/j.yrtph.2021.104920. PMID: 33757807.

View Abstract

Wang Y, Mittelstaedt RA, Wynne R, Chen Y, Cao X, Muskhelishvili L, Davis K, Robison TW, et al. 2021. Genetic toxicity testing using human in vitro organotypic airway cultures: Assessing DNA damage with the CometChip and mutagenesis by duplex sequencing. Environ Mol Mutagen 62(5):306-318; doi: 10.1002/em22444.

View Abstract

Choksi NY, Daniel AB, Allen DG, Clippinger AJ, Kleinstreuer NC. 2021. Prospective and retrospective evaluation of the eye irritation potential of agrochemical formulations. Research Triangle Park, NC: National Toxicology Program. NICEATM Report 01.

View Abstract

O’Neil HC, Vincent MJ, Han AA, Brown SE, Hazell AM, Krieder ML, Madl AM. Hazard and risk banding framework for prioritization and bridging of e-liquids for toxicity testing. Poster presented at Society of Toxicology 60th Annual Meeting, Virtual, March 2021.

View Abstract

Rooney JP, Choksi N, Ceger P, Daniel AB, Truax J, Allen DG, Kleinstreuer NC. Variability in the rabbit skin irritation assay. Poster presented at Society of Toxicology 60th Annual Meeting, Virtual, March 2021.

View Abstract

2020 (3 POSTS)

Eskes C, Corsini E, Hanley V, Karadjova I, Kopp-Schneider A, Suh M, Alves P, Clewell R, et al. 2020. ESAC opinion on the scientific validity of the bioelution test method. In: Viegas Barroso J (ed), EUR 30281 EN. Publications Office of the European Union, Luxembourg, ISBN 978-92-76-20004-8 (online), doi:10.2760/023005 (online), JRC121143.

View Abstract

Choksi N, Clippinger AJ, Gehen S, Corvaro M, Kolle SN, Bentley K, et al. Developing a defined approach for eye irritation testing. Poster presented at Society of Toxicology 59th Annual Meeting, Virtual, March 2020.

View Abstract

Choksi N, Lebrun S, Nguyen M, Daniel A, DeGeorge G, Willoughby J, et al. 2020. Validation of the OptiSafe eye irritation test. Cutan Ocul Toxicol 39(3):180–192; doi: 10.1080/15569527.2020.1787431. PMID: 32586141.

View Abstract

2019 (2 POSTS)

Choksi NY, Truax J, Layton A, Matheson J, Mattie D, Varney T, et al. 2019. United States regulatory requirements for skin and eye irritation testing. Cutan Ocul Toxicol 38(2):141–155; doi: 10.1080/15569527.2018.1540494. PMID: 30418044.

View Abstract

Patlewicz G, Richard AM, Williams AJ, Grulke CM, Sams R, Lambert J, Noyes P, DeVito MJ, et al. 2019. A chemical category-based prioritization approach for selecting 75 per- and polyfluoroalkyl substances (PFAS) for tiered toxicity and toxicokinetic testing. Environ Health Perspect 127(1):14501; doi: 10.1289/EHP4555. PMID: 30632786.

View Abstract

2018 (1 POST)

Klaren WD, Rusyn I. 2018. High-content assay multiplexing for muscle toxicity screening in human-induced pluripotent stem cell-derived skeletal myoblasts. Assay Drug Dev Technol 16(6):333–342; doi: 10.1089/adt.2018.86. PMID: 30070899.

View Abstract

2017 (5 POSTS)

Iwata Y, Klaren WD, Lebakken CS, Grimm FA, Rusyn I. 2017. High-content assay multiplexing for vascular toxicity screening in induced pluripotent stem cell-derived endothelial cells and human umbilical vein endothelial cells. Assay Drug Dev Technol 15(6):267–279; doi: 10.1089/adt.2017.786. PMID: 28771372.

View Abstract

Sheppard A, Baker E, Bermudez D, Blattner J, Boyd K, O’Neal S, Rahim T, Whittle E. Implementing an alternate testing strategy for assessing skin irritation. Abstract #2734, Society of Toxicology 56th Annual Meeting, Baltimore, MD, 2017.

View Abstract

Sheppard A, Baker E, Bermudez D, Blattner J, Boyd K, O’Neal S, Rahim T, Whittle E. Use of alternative methods to assess skin irritation of chemical mixtures. World Congress for Alternatives to Animal Testing, Seattle, WA, 2017.

Ceger P, Choksi N, Hamm J, Truax J, Daniel A, Allen D, et al. Development of a curated database of in vivo developmental toxicity data. Poster presented at Society of Toxicology 56th Annual Meeting, Baltimore, MD, March 2017.

View Abstract

Panko J, Hitchcock K, Fung M, Spencer PJ, Kingsbury T, Mason AM. 2017. A comparative evaluation of five hazard screening tools. Integr Environ Assess Manag 13(1):139–154; doi: 10.1002/ieam.1757. PMID: 26777143.

 

View Abstract
Page 1 of 3
123